Gut microbiome-mediated mechanisms in aging-related diseases: are probiotics ready for prime time?

Chronic low-grade inflammation affects health and is associated with aging and age-related diseases. Dysregulation of the gut flora is an important trigger for chronic low-grade inflammation. Changes in the composition of the gut flora and exposure to related metabolites have an effect on the inflam...

Full description

Bibliographic Details
Main Authors: Jing Ren, Huimin Li, Guixing Zeng, Boxian Pang, Qiuhong Wang, Junping Wei
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-06-01
Series:Frontiers in Pharmacology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fphar.2023.1178596/full
_version_ 1797814286400094208
author Jing Ren
Jing Ren
Huimin Li
Guixing Zeng
Boxian Pang
Boxian Pang
Qiuhong Wang
Junping Wei
author_facet Jing Ren
Jing Ren
Huimin Li
Guixing Zeng
Boxian Pang
Boxian Pang
Qiuhong Wang
Junping Wei
author_sort Jing Ren
collection DOAJ
description Chronic low-grade inflammation affects health and is associated with aging and age-related diseases. Dysregulation of the gut flora is an important trigger for chronic low-grade inflammation. Changes in the composition of the gut flora and exposure to related metabolites have an effect on the inflammatory system of the host. This results in the development of crosstalk between the gut barrier and immune system, contributing to chronic low-grade inflammation and impairment of health. Probiotics can increase the diversity of gut microbiota, protect the gut barrier, and regulate gut immunity, thereby reducing inflammation. Therefore, the use of probiotics is a promising strategy for the beneficial immunomodulation and protection of the gut barrier through gut microbiota. These processes might positively influence inflammatory diseases, which are common in the elderly.
first_indexed 2024-03-13T08:05:22Z
format Article
id doaj.art-8d4bdd5ec9ce46608cbbeef064f7c42a
institution Directory Open Access Journal
issn 1663-9812
language English
last_indexed 2024-03-13T08:05:22Z
publishDate 2023-06-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Pharmacology
spelling doaj.art-8d4bdd5ec9ce46608cbbeef064f7c42a2023-06-01T05:17:48ZengFrontiers Media S.A.Frontiers in Pharmacology1663-98122023-06-011410.3389/fphar.2023.11785961178596Gut microbiome-mediated mechanisms in aging-related diseases: are probiotics ready for prime time?Jing Ren0Jing Ren1Huimin Li2Guixing Zeng3Boxian Pang4Boxian Pang5Qiuhong Wang6Junping Wei7Department of Endocrinology, Guang’anmen Hospital, China Academy of Chinese Medical Sciences, Beijing, ChinaGraduate School of Beijing University of Chinese Medicine, Beijing, ChinaDepartment of Endocrinology, Guang’anmen Hospital, China Academy of Chinese Medical Sciences, Beijing, ChinaDepartment of Endocrinology, Guang’anmen Hospital, China Academy of Chinese Medical Sciences, Beijing, ChinaDepartment of Endocrinology, Guang’anmen Hospital, China Academy of Chinese Medical Sciences, Beijing, ChinaGraduate School of Beijing University of Chinese Medicine, Beijing, ChinaDepartment of Endocrinology, Guang’anmen Hospital, China Academy of Chinese Medical Sciences, Beijing, ChinaDepartment of Endocrinology, Guang’anmen Hospital, China Academy of Chinese Medical Sciences, Beijing, ChinaChronic low-grade inflammation affects health and is associated with aging and age-related diseases. Dysregulation of the gut flora is an important trigger for chronic low-grade inflammation. Changes in the composition of the gut flora and exposure to related metabolites have an effect on the inflammatory system of the host. This results in the development of crosstalk between the gut barrier and immune system, contributing to chronic low-grade inflammation and impairment of health. Probiotics can increase the diversity of gut microbiota, protect the gut barrier, and regulate gut immunity, thereby reducing inflammation. Therefore, the use of probiotics is a promising strategy for the beneficial immunomodulation and protection of the gut barrier through gut microbiota. These processes might positively influence inflammatory diseases, which are common in the elderly.https://www.frontiersin.org/articles/10.3389/fphar.2023.1178596/fullprobioticsinflammationgut microbiotaintestinal barrierdysbiosiselderly
spellingShingle Jing Ren
Jing Ren
Huimin Li
Guixing Zeng
Boxian Pang
Boxian Pang
Qiuhong Wang
Junping Wei
Gut microbiome-mediated mechanisms in aging-related diseases: are probiotics ready for prime time?
Frontiers in Pharmacology
probiotics
inflammation
gut microbiota
intestinal barrier
dysbiosis
elderly
title Gut microbiome-mediated mechanisms in aging-related diseases: are probiotics ready for prime time?
title_full Gut microbiome-mediated mechanisms in aging-related diseases: are probiotics ready for prime time?
title_fullStr Gut microbiome-mediated mechanisms in aging-related diseases: are probiotics ready for prime time?
title_full_unstemmed Gut microbiome-mediated mechanisms in aging-related diseases: are probiotics ready for prime time?
title_short Gut microbiome-mediated mechanisms in aging-related diseases: are probiotics ready for prime time?
title_sort gut microbiome mediated mechanisms in aging related diseases are probiotics ready for prime time
topic probiotics
inflammation
gut microbiota
intestinal barrier
dysbiosis
elderly
url https://www.frontiersin.org/articles/10.3389/fphar.2023.1178596/full
work_keys_str_mv AT jingren gutmicrobiomemediatedmechanismsinagingrelateddiseasesareprobioticsreadyforprimetime
AT jingren gutmicrobiomemediatedmechanismsinagingrelateddiseasesareprobioticsreadyforprimetime
AT huiminli gutmicrobiomemediatedmechanismsinagingrelateddiseasesareprobioticsreadyforprimetime
AT guixingzeng gutmicrobiomemediatedmechanismsinagingrelateddiseasesareprobioticsreadyforprimetime
AT boxianpang gutmicrobiomemediatedmechanismsinagingrelateddiseasesareprobioticsreadyforprimetime
AT boxianpang gutmicrobiomemediatedmechanismsinagingrelateddiseasesareprobioticsreadyforprimetime
AT qiuhongwang gutmicrobiomemediatedmechanismsinagingrelateddiseasesareprobioticsreadyforprimetime
AT junpingwei gutmicrobiomemediatedmechanismsinagingrelateddiseasesareprobioticsreadyforprimetime